![](/images/general/no_picture/200_user.png)
Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12637296
[patent_doc_number] => 20180104262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 15/711502
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15711502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/711502 | SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND | Sep 20, 2017 | Abandoned |
Array
(
[id] => 15432149
[patent_doc_number] => 20200030257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING GALLSTONE SOLUBILIZER FOR TREATMENT OF GALLBLADDER DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/461785
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461785 | Pharmaceutical composition comprising gallstone solubilizer for treatment of gallbladder disease | Sep 18, 2017 | Issued |
Array
(
[id] => 14743799
[patent_doc_number] => 20190255073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/333451
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333451
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333451 | ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS | Sep 14, 2017 | Abandoned |
Array
(
[id] => 12580425
[patent_doc_number] => 20180085304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => OTIC GEL FORMULATIONS FOR TREATING OTITIS EXTERNA
[patent_app_type] => utility
[patent_app_number] => 15/705101
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705101 | Otic gel formulations for treating otitis externa | Sep 13, 2017 | Issued |
Array
(
[id] => 14649317
[patent_doc_number] => 20190231787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => METHODS AND COMPOUNDS FOR TREATING ALCOHOL USE DISORDERS AND ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/327803
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327803 | METHODS AND COMPOUNDS FOR TREATING ALCOHOL USE DISORDERS AND ASSOCIATED DISEASES | Aug 24, 2017 | Abandoned |
Array
(
[id] => 14438973
[patent_doc_number] => 20190177359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID
[patent_app_type] => utility
[patent_app_number] => 16/326977
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326977 | Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid | Aug 22, 2017 | Issued |
Array
(
[id] => 12091236
[patent_doc_number] => 20170348329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'Combination Drug Therapy'
[patent_app_type] => utility
[patent_app_number] => 15/684240
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17516
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684240 | Combination Drug Therapy | Aug 22, 2017 | Abandoned |
Array
(
[id] => 12979696
[patent_doc_number] => 20170342103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/681983
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 673
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681983
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/681983 | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof | Aug 20, 2017 | Issued |
Array
(
[id] => 14372247
[patent_doc_number] => 20190160036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => APPLICATION OF PHOSPHODIESTERASE 4 INHIBITOR ZL-N-91 IN PREPARATION OF MEDICAMENT FOR TREATING PROSTATE CANCER PROLIFERATION AND METASTASIS
[patent_app_type] => utility
[patent_app_number] => 16/322112
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322112 | APPLICATION OF PHOSPHODIESTERASE 4 INHIBITOR ZL-N-91 IN PREPARATION OF MEDICAMENT FOR TREATING PROSTATE CANCER PROLIFERATION AND METASTASIS | Aug 7, 2017 | Abandoned |
Array
(
[id] => 16009119
[patent_doc_number] => 20200179402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => MONOHYDROXYLATED 17ALPHA-HYDROXYPROGESTERONE CAPROATE FOR REDUCING CONTRACTILITY
[patent_app_type] => utility
[patent_app_number] => 16/321965
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321965 | MONOHYDROXYLATED 17ALPHA-HYDROXYPROGESTERONE CAPROATE FOR REDUCING CONTRACTILITY | Aug 2, 2017 | Abandoned |
Array
(
[id] => 14911075
[patent_doc_number] => 10426837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Compositions and methods for treating CNS disorders
[patent_app_type] => utility
[patent_app_number] => 15/660114
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32872
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660114
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660114 | Compositions and methods for treating CNS disorders | Jul 25, 2017 | Issued |
Array
(
[id] => 12151510
[patent_doc_number] => 20180022775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/660470
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 45829
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660470
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660470 | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof | Jul 25, 2017 | Issued |
Array
(
[id] => 14864599
[patent_doc_number] => 20190282541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/318198
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318198
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318198 | USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER | Jul 19, 2017 | Abandoned |
Array
(
[id] => 14682169
[patent_doc_number] => 20190240199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => TREATMENT FOR GLIOBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 16/318468
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318468 | Treatment for glioblastoma | Jul 19, 2017 | Issued |
Array
(
[id] => 12023641
[patent_doc_number] => 20170313739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'TACCALONOLIDE MICROTUBULE STABILIZERS'
[patent_app_type] => utility
[patent_app_number] => 15/653397
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23689
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15653397
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/653397 | Taccalonolide microtubule stabilizers | Jul 17, 2017 | Issued |
Array
(
[id] => 12231866
[patent_doc_number] => 20180064729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'Treatment of Pulmonary Disease'
[patent_app_type] => utility
[patent_app_number] => 15/652777
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16091
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652777
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/652777 | Treatment of Pulmonary Disease | Jul 17, 2017 | Abandoned |
Array
(
[id] => 12124956
[patent_doc_number] => 20180008543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Cleavable Lipids'
[patent_app_type] => utility
[patent_app_number] => 15/651832
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28390
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651832
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651832 | Cleavable Lipids | Jul 16, 2017 | Abandoned |
Array
(
[id] => 16007375
[patent_doc_number] => 20200178530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CRYSTALLINE FORM C OF SHUANGZUOCAOTONG, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/629879
[patent_app_country] => US
[patent_app_date] => 2017-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629879 | Crystalline form C of shuangzuocaotong, preparation method therefor and use thereof | Jul 14, 2017 | Issued |
Array
(
[id] => 14883491
[patent_doc_number] => 10421772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Steroids as agonists for FXR
[patent_app_type] => utility
[patent_app_number] => 15/645136
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645136 | Steroids as agonists for FXR | Jul 9, 2017 | Issued |
Array
(
[id] => 14883491
[patent_doc_number] => 10421772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Steroids as agonists for FXR
[patent_app_type] => utility
[patent_app_number] => 15/645136
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645136 | Steroids as agonists for FXR | Jul 9, 2017 | Issued |